Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for the Treatment of Osteoarthritis
NCT00686439Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Jun 2008
- Primary completion
- Nov 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of adalimumab in osteoarthritis (OA), sponsored by University of Alberta. Primary endpoint: Osteoarthritis Research Society International / Outcome Measures in Rheumatology response at 12 weeks. Started Jun 2008; status: completed.
02
Drugs
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00686439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686439.